China is challenging the United States for market share and jobs in one of the highest value-added, most innovation-intensive industries—and the risks extend not just to the U.S. economy, but to global biopharma innovation.
December 21, 2015
From alarmists touting an artificial intelligence apocalypse to activists fighting against genetically improved foods, this report highlights 10 of the year’s most egregious cases of neo-Luddism in action.
December 8, 2015
While many parts of the Trans-Pacific Partnership agreement will positively impact bio innovation, others will inhibit the development of the next generation of breakthrough medicines, said Stephen Ezell in testimony before the House Ways and Means Committee Democratic Members.
November 5, 2015
In comments to the White House Office of Science and Technology Policy, ITIF's Val Giddings argues there is no relationship between the degree of regulatory scrutiny a biotechnology product receives and the degree of hazard it represents.
June 22, 2015
A new paper shows that innovative treatments are adding years to cancer patients' lives.
April 16, 2015
Turkey's leaders need to create a more supportive environment for trade, investment, and innovation.
April 9, 2015
New research shows the value of medical innovation is much higher than previously estimated.
March 17, 2015
How Canada is killing innovation in its pharmaceutical industry.
March 16, 2015
Smart regulatory reform focused on sectors that compete internationally can boost U.S. economic competitiveness while maintaining, or even increasing, social benefits.
March 9, 2015
To ensure the Trans-Pacific Partnership (TPP) Agreement creates a framework in which life sciences innovation flourishes throughout the TPP region, it needs to include 12 years of data protection for novel biologic drugs.
February 26, 2015
The National Institutes of Health needs greater resources and more funding stability.